Related references
Note: Only part of the references are listed.被撤回的出版物: Dual Role of Interleukin-6 in Regulating Insulin Sensitivity in Murine Skeletal Muscle (Retracted article. See vol. 69, pg. 2537, 2020)
Iria Nieto-Vazquez et al.
DIABETES (2008)
Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitus
J. Ybarra et al.
DIABETES & METABOLISM (2008)
Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study
J. Saltevo et al.
DIABETIC MEDICINE (2008)
Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice
S. Franckhauser et al.
DIABETOLOGIA (2008)
The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia
Nadine S. Sauter et al.
ENDOCRINOLOGY (2008)
Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus
G. R. C. Zilverschoon et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Increased interleukin (IL)-1β messenger ribonucleic acid expression in β-cells of individuals with type 2 diabetes and regulation of IL-1β in human islets by glucose and autostimulation
Marianne Boni-Schnetzler et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Interleukin-6 regulates pancreatic α-cell mass expansion
Helga Ellingsgaard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway
Jeong-Ho Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss
Jens M. Bruun et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Increased number of islet-associated macrophages in type 2 diabetes
Jan A. Ehses et al.
DIABETES (2007)
Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle
Stephan Glund et al.
DIABETES (2007)
IL-6 increases muscle insulin sensitivity only at superphysiological levels
Paige C. Geiger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance
Cynthia A. Nagle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Claus M. Larsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Interleukin-1 beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression
Jennifer Jager et al.
ENDOCRINOLOGY (2007)
Disordered lipid metabolism and the pathogenesis of insulin resistance
David B. Savage et al.
PHYSIOLOGICAL REVIEWS (2007)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle
Lubna Al-Khalili et al.
MOLECULAR ENDOCRINOLOGY (2006)
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase
Andrew L. Carey et al.
DIABETES (2006)
Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes
C. Lagathu et al.
DIABETOLOGIA (2006)
Interleukin-1 system gene polymorphisms are associated with fat mass in young men
Louise Strandberg et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance
MG Netea et al.
NATURE MEDICINE (2006)
Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells
C Weigert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents
E Somm et al.
DIABETOLOGIA (2006)
Interleukin-1 alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes
JY He et al.
MOLECULAR ENDOCRINOLOGY (2006)
Decreased fat mass in interleukin-1 receptor antagonist-deficient mice - Impact on adipogenesis, food intake, and energy expenditure
E Somm et al.
DIABETES (2005)
Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans
CP Fischer et al.
CLINICAL IMMUNOLOGY (2005)
Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt
C Weigert et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Interleukin-6 depletion selectively improves hepatic insulin action in obesity
PJ Klover et al.
ENDOCRINOLOGY (2005)
Mitochondrial glycerol-3-phosphate acyltransferase-1 is essential in liver for the metabolism of excess acyl-CoAs
LE Hammond et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
DS Cai et al.
NATURE MEDICINE (2005)
Anakinra - A review of its use in the management of rheumatoid arthritis
J Waugh et al.
BIODRUGS (2005)
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
BB Kahn et al.
CELL METABOLISM (2005)
Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro
EW Petersen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and Adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans
JN Fain et al.
ENDOCRINOLOGY (2004)
Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity
N Hiscock et al.
FASEB JOURNAL (2004)
PKC-θ knockout mice are protected from fat-induced insulin resistance
JK Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome
U Salmenniemi et al.
CIRCULATION (2004)
Glucose- and interleukin-1β-induced β-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor l/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets
K Maedler et al.
DIABETES (2004)
Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue
JM Bruun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction
MA Febbraio et al.
DIABETES (2004)
Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity
GB Di Gregorio et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro
ME Trujillo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in rats
VR Sopasakis et al.
DIABETOLOGIA (2004)
Regulatory effects of interleukin (IL)-1, interferon-β, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue
CE Juge-Aubry et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Leptin modulates β cell expression of IL-1 receptor antagonist and release of IL-lβ in human islets
K Maedler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone
C Lagathu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects
V Rotter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions
T Matsuki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Molecular phylogeny within type I cytokines and their cognate receptors
JL Boulay et al.
IMMUNITY (2003)
Interleukin-6 stimulates lipolysis and fat oxidation in humans
G van Hall et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Adipose tissue is a major source of interleukin-1 receptor antagonist - Upregulation in obesity and inflammation
CE Juge-Aubry et al.
DIABETES (2003)
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes
JJ Senn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans
A Steensberg et al.
JOURNAL OF PHYSIOLOGY-LONDON (2003)
Inflammatory cytokines and the risk to develop type 2 diabetes -: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study
J Spranger et al.
DIABETES (2003)
Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice
PJ Klover et al.
DIABETES (2003)
Interleukin-6 induces cellular insulin resistance in hepatocytes
JJ Senn et al.
DIABETES (2002)
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
K Maedler et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Immunomodulatory actions of leptin
CE Juge-Aubry et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Metabolic effects of interleukin-6 in human splanchnic and adipose tissue
D Lyngso et al.
JOURNAL OF PHYSIOLOGY-LONDON (2002)
Leptin induces IL-1 receptor antagonist expression in the brain
T Hosoi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Interleukin-6-deficient mice develop mature-onset obesity
V Wallenius et al.
NATURE MEDICINE (2002)
Global and societal implications of the diabetes epidemic
P Zimmet et al.
NATURE (2001)
Glucose induces β-cell apoptosis via upregulation of the Fas receptor in human islets
K Maedler et al.
DIABETES (2001)
Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice
R Horai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene
MJH Nicklin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
